Relationship of DDX1 and NAG gene amplification/overexpression to the prognosis of patients with MYCN-amplified neuroblastoma (Q34572353)

3 August 2017

title

Relationship of DDX1 and NAG gene amplification/overexpression to the prognosis of patients with MYCN-amplified neuroblastoma (English)

1 reference

3 August 2017

1 reference

Setsuko Kaneko

1

1 reference

3 August 2017

Miki Ohira

2

1 reference

3 August 2017

Yohko Nakamura

3

1 reference

3 August 2017

Eriko Isogai

4

1 reference

3 August 2017

Akira Nakagawara

5

1 reference

3 August 2017

Michio Kaneko

6

1 reference

3 August 2017

publication date

7 October 2006

1 reference

Journal of Cancer Research and Clinical Oncology

3 August 2017

published in

1 reference

3 August 2017

volume

133

1 reference

3 August 2017

issue

3

1 reference

3 August 2017

page(s)

185-192

1 reference

https://scigraph.springernature.com/pub.10.1007/s00432-006-0156-y

3 August 2017

exact match

0 references

cites work

Amplified N-myc in human neuroblastoma cells is often arranged as clustered tandem repeats of differently recombined DNA.

1 reference

https://api.crossref.org/works/10.1007%2FS00432-006-0156-Y

Chromosomal localization of DNA amplifications in neuroblastoma tumors using cDNA microarray comparative genomic hybridization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-006-0156-Y

Association of human DEAD box protein DDX1 with a cleavage stimulation factor involved in 3'-end processing of pre-MRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-006-0156-Y

Cloning and expression analysis of the chicken DEAD box gene DDX1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-006-0156-Y

International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.

21 January 2018

1 reference

12 December 2020

Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage

1 reference

12 December 2020

A novel human homologue of a dead-box RNA helicase family

1 reference

12 December 2020

No Evidence for Correlation of DDX1 Gene Amplification With Improved Survival Probability in Patients With MYCN-Amplified Neuroblastomas

1 reference

12 December 2020

Co-amplification of MYCN and a DEAD box gene (DDX1) in primary neuroblastoma

1 reference

12 December 2020

Coamplification of DDX1 correlates with an improved survival probability in children with MYCN-amplified human neuroblastoma.

1 reference

12 December 2020

The role of age in neuroblastoma risk stratification: the German, Italian, and children's oncology group perspectives

1 reference

12 December 2020

mRNAs can be stabilized by DEAD-box proteins

1 reference

12 December 2020

D-E-A-D protein family of putative RNA helicases

1 reference

12 December 2020

Quick quantitative analysis of gene dosages associated with prognosis in neuroblastoma

1 reference

12 December 2020

A second maternally expressed Drosophila gene encodes a putative RNA helicase of the "DEAD box" family

1 reference

12 December 2020

Intensified chemotherapy increases the survival rates in patients with stage 4 neuroblastoma with MYCN amplification

1 reference

12 December 2020

Real-time quantitative PCR for the measurement of MYCN amplification in human neuroblastoma with the TaqMan detection system

1 reference

12 December 2020

Quantification of MYCN, DDX1, and NAG gene copy number in neuroblastoma using a real-time quantitative PCR assay.

1 reference

12 December 2020

Physical mapping of the DDX1 gene to 340 kb 5' of MYCN

1 reference

12 December 2020

Treatment results of advanced neuroblastoma with the first Japanese study group protocol. Study Group of Japan for Treatment of Advanced Neuroblastoma

1 reference

12 December 2020

Co-amplification and concomitant high levels of expression of a DEAD box gene with MYCN in human neuroblastoma

1 reference

12 December 2020

Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: a Children's Cancer Group Study

1 reference

12 December 2020

Analysis of candidate gene co-amplification with MYCN in neuroblastoma

1 reference

12 December 2020

An RNA helicase, DDX1, interacting with poly(A) RNA and heterogeneous nuclear ribonucleoprotein K

1 reference

12 December 2020

Clinical significance of a highly sensitive analysis for gene dosage and the expression level of MYCN in neuroblastoma

1 reference

12 December 2020

The neuroblastoma amplified gene, NAG : genomic structure and characterisation of the 7.3 kb transcript predominantly expressed in neuroblastoma

1 reference

12 December 2020

Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas

1 reference

12 December 2020

DExD/H box RNA helicases: from generic motors to specific dissociation functions

1 reference

12 December 2020

Genes co-amplified with MYCN in neuroblastoma: silent passengers or co-determinants of phenotype?

1 reference

12 December 2020

Multicentre analysis of patterns of DNA gains and losses in 204 neuroblastoma tumors: how many genetic subgroups are there?

1 reference

12 December 2020

Amplification of a DEAD box protein gene in retinoblastoma cell lines

1 reference

12 December 2020

International neuroblastoma pathology classification adds independent prognostic information beyond the prognostic contribution of age.

1 reference

12 December 2020

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

1 reference

12 December 2020

Gene amplification in human neuroblastomas: basic mechanisms and clinical implications

1 reference

12 December 2020

10.1007/S00432-006-0156-Y

Identifiers

DOI

1 reference

3 August 2017

1 reference